Chen Xinglong, Xu Ling, Liu Renrong, Qiu Xuemei, Zhu Lixin
School of Life Science, Jiangxi Science and Technology Normal University, Nanchang 330013, China.
Wei Sheng Yan Jiu. 2012 Sep;41(5):814-8.
Traditional ochratoxin A(OTA) competitive antigen are high toxicity, high price and difficult preparation. Non-toxic and easy prepared OTA competitive antigen substitutes were expressed by recombinant filamentous phage which have OTA mimotope displayed on its p VI surface.
Recombinant phagemid pC89-COTA which contain OTA mimotope nucleotide sequence was constructed. Moreover, to increase the binding rate of OTA mimotope with antibody, Enterokinase cleavage sits were led into 5' terminal of OTA mimotope nucleotide sequence. The pC89-COTA was transformed into E. coli XL1-blue. The E. coli XL1-blue were infected by wild KM13 phage and recombinant phage with OTA mimotope displayed generated.
OTA mimotope phage was successful expressed and OTA mimotope phage which digested by Enterokinase had significantly higher binding rate with antibody than phage which not digested by Enterokinase. Non-toxic OTA competitive ELISA was established by using this digested OTA mimotope phage, the detecting limitation was 100 microg/ml, the linear range of the inhibition curves was between 250 pg/ml and 1000 pg/ml. Spiked recoveries of the farina tritici blank samples, the recovery rate of OTA were 99.8% 112.3% and coefficients of variation were 8.19% 11.64%, then 16 commercially available samples were tested and the positive rate was 31.25%.
OTA mimotope phage were successfully expressed and non-toxic OTA competitive ELISA was established.
传统的赭曲霉毒素A(OTA)竞争性抗原毒性高、价格昂贵且制备困难。通过在其pVI表面展示有OTA模拟表位的重组丝状噬菌体表达无毒且易于制备的OTA竞争性抗原替代物。
构建含有OTA模拟表位核苷酸序列的重组噬菌粒pC89-COTA。此外,为提高OTA模拟表位与抗体的结合率,将肠激酶切割位点引入OTA模拟表位核苷酸序列的5'末端。将pC89-COTA转化至大肠杆菌XL1-blue中。用野生型KM13噬菌体感染大肠杆菌XL1-blue,产生展示有OTA模拟表位的重组噬菌体。
成功表达了OTA模拟表位噬菌体,经肠激酶消化的OTA模拟表位噬菌体与抗体的结合率显著高于未经肠激酶消化的噬菌体。利用这种经消化的OTA模拟表位噬菌体建立了无毒OTA竞争性ELISA,检测限为100μg/ml,抑制曲线的线性范围在250pg/ml至1000pg/ml之间。对小麦粉空白样品进行加标回收试验,OTA的回收率为99.8%至112.3%,变异系数为8.19%至11.64%,随后对16份市售样品进行检测,阳性率为31.25%。
成功表达了OTA模拟表位噬菌体并建立了无毒OTA竞争性ELISA。